Conolidine’s analgesic results stem from its interaction with non-opioid pain pathways. As opposed to opioids, which bind to µ-opioid receptors during the central nervous program, conolidine modulates alternate molecular targets. A Science Developments research located that conolidine interacts With all the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide https://the-new-pain-killer-conol45428.designertoblog.com/69222123/about-alternative-natural-pain-relief-to-replace-traditional-painkillers